155 related articles for article (PubMed ID: 3680606)
1. View from the Nation's Capital. FDA challenged successfully on its policies regarding good manufacturing practice inspections of medical drug and device manufacturers.
Appler WD
J Clin Psychopharmacol; 1987 Oct; 7(5):346-7. PubMed ID: 3680606
[No Abstract] [Full Text] [Related]
2. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408
[No Abstract] [Full Text] [Related]
3. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Feb; 3(1):47-8. PubMed ID: 6680403
[No Abstract] [Full Text] [Related]
4. View from the Nation's Capital.
Freishtat HW
J Clin Psychopharmacol; 1985 Apr; 5(2):117-9. PubMed ID: 3988970
[No Abstract] [Full Text] [Related]
5. View from the Nation's Capital. FDA moves forward (and backwards) on a number of simmering issues.
Appler WD
J Clin Psychopharmacol; 1988 Feb; 8(1):57-8. PubMed ID: 3351001
[No Abstract] [Full Text] [Related]
6. Medical devices; current good manufacturing practice (CGMP) final fule; quality system regulation--FDA. Final rule.
Fed Regist; 1996 Oct; 61(195):52602-62. PubMed ID: 10168287
[TBL] [Abstract][Full Text] [Related]
7. FDA inspections of large volume and small volume parenteral manufacturers.
Shepherd RE
Bull Parenter Drug Assoc; 1976; 30(5):209-13. PubMed ID: 974306
[No Abstract] [Full Text] [Related]
8. Mutual recognition of pharmaceutical good manufacturing practice inspection reports, medical device quality system audit reports, and certain medical device product evaluation reports between the United States and the European Community--FDA. Final rule.
Fed Regist; 1998 Nov; 63(215):60122-64. PubMed ID: 10187390
[TBL] [Abstract][Full Text] [Related]
9. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
[TBL] [Abstract][Full Text] [Related]
10. Letter to manufacturers of blood establishment computer software products--FDA. Notice.
Fed Regist; 1994 Aug; 59(168):44991-2. PubMed ID: 10136917
[TBL] [Abstract][Full Text] [Related]
11. Sterilizers and the medical device directive.
Donawa ME
Med Device Technol; 1994 May; 5(4):10, 12. PubMed ID: 10147069
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
[TBL] [Abstract][Full Text] [Related]
13. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Feb; 4(1):52-4. PubMed ID: 6096407
[No Abstract] [Full Text] [Related]
14. View from the Nation's Capital.
Appler WD
J Clin Psychopharmacol; 1986 Feb; 6(1):42-4. PubMed ID: 3950066
[No Abstract] [Full Text] [Related]
15. View from the Nation's Courts.
Freishtat HW
J Clin Psychopharmacol; 1982 Aug; 2(4):290-2. PubMed ID: 6926927
[No Abstract] [Full Text] [Related]
16. View from the nation's capital.
Romansky MA
J Clin Psychopharmacol; 1985 Feb; 5(1):51-2. PubMed ID: 2982923
[No Abstract] [Full Text] [Related]
17. Implications of the Lannett and Pharmadyne decisions.
Vetrano AJ
Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217
[TBL] [Abstract][Full Text] [Related]
18. What physicians should know about the regulation of Obstetric and Gynecologic Medical Devices.
Yin L
J Reprod Med; 1983 Jan; 28(1):3-11. PubMed ID: 6834344
[TBL] [Abstract][Full Text] [Related]
19. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Oct; 4(5):288-9. PubMed ID: 6096409
[No Abstract] [Full Text] [Related]
20. Final FDA inspection manual.
Donawa M
Med Device Technol; 2001 Apr; 12(3):29-32. PubMed ID: 11547684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]